Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.16.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 23 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-52.25
EARNINGS PER SHARE (EPS) AVG 3Y
-46.52
EARNINGS PER SHARE (EPS) AVG 5Y
-41.75
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Vor Biopharma Inc.
Market Cap
$999.21M
Earnings Per Share (EPS)
N/A
TTM Avg
-52.25
3Y Avg
-46.52
5Y Avg
-41.75
Market Cap
$1.01B
Earnings Per Share (EPS)
-3.37
TTM Avg
-3.42
3Y Avg
-2.02
5Y Avg
-1.79
Market Cap
$991.66M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$996.15M
Earnings Per Share (EPS)
-1.94
TTM Avg
-1.73
3Y Avg
-1.92
5Y Avg
-1.76
Market Cap
$987.57M
Earnings Per Share (EPS)
0.71
TTM Avg
-1.77
3Y Avg
-1.98
5Y Avg
-1.86
Market Cap
$1.01B
Earnings Per Share (EPS)
-1.84
TTM Avg
-0.83
3Y Avg
-0.99
5Y Avg
-2.01
Market Cap
$985.68M
Earnings Per Share (EPS)
-2.97
TTM Avg
-9.41
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$1.02B
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.08
3Y Avg
-1.22
5Y Avg
-1.11
Market Cap
$978.87M
Earnings Per Share (EPS)
0.35
TTM Avg
-0.99
3Y Avg
-0.18
5Y Avg
0.61
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vor Biopharma Inc. (VOR) | $999.21M | N/A | -52.25 | -46.52 | -41.75 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | -3.37 | -3.42 | -2.02 | -1.79 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $991.66M | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.15M | -1.94 | -1.73 | -1.92 | -1.76 |
| MeiraGTx Holdings plc (MGTX)vs › | $987.57M | 0.71 | -1.77 | -1.98 | -1.86 |
| Immatics N.V. (IMTX)vs › | $1.01B | -1.84 | -0.83 | -0.99 | -2.01 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $985.68M | -2.97 | -9.41 | -6.16 | -6.16 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | -0.66 | -0.08 | -1.22 | -1.11 |
| Pacira BioSciences, Inc. (PCRX)vs › | $978.87M | 0.35 | -0.99 | -0.18 | 0.61 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | -0.38 | -0.83 | -0.98 | -0.98 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-7.21
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -70.50 |
| 2024-12-31 | -34.00 |
| 2023-12-31 | -35.00 |
| 2022-12-31 | -46.60 |
| 2021-12-31 | -37.80 |
| 2020-12-31 | -26.60 |
| 2019-12-31 | -6.20 |
| 2018-12-31 | -14.60 |
